Orally effective iron chelators for the treatment of iron overload disease: The case for a further look at pyridoxal isonicotinoyl hydrazone and its analogs
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Thus, pyridoxal isonicotinyl hydrazone (PIH) [1672,1715-1720] is a promising molecule (also proposed in anti-cancer therapy), although it is hydrolysed both in vivo and in vitro [1721].”
From Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases (2009) · cites this paper as [1715]
Citations
Cites
Iron-Chelating Therapy and the Treatment of Thalassemia
Olivieri, N. F., & Brittenham, G. M. (1997) · Blood · doi:10.1182/blood.v89.3.739 · Cited by 1,089
Long-Term Trial of Deferiprone in 51 Transfusion-Dependent Iron Overloaded Patients
Hoffbrand, A. V., AL-Refaie, F., Davis, B., Siritanakatkul, N., Jackson, B. F. A., Cochrane, J., Prescott, E., & Wonke, B. (1998) · Blood · doi:10.1182/blood.v91.1.295 · Cited by 205
Richardson, D. R., & Ponka, P. (1998) · Journal of Laboratory and Clinical Medicine · doi:10.1016/s0022-2143(98)90180-9 · Cited by 126
Self-citationPyridoxal isonicotinoyl hydrazone: an effective iron-chelator after oral administration.
Brittenham, G. M. (1990) · PubMed · Cited by 61
Biliary Iron Excretion in Rats Following Treatment With Analogs of Pyridoxal Isonicotinoyl Hydrazone
Bláha, K., Cikrt, M., Nerudová, J., Fornusková, H., & Ponka, P. (1998) · Blood · doi:10.1182/blood.v91.11.4368 · Cited by 26
Iron chelation therapy: The need for orally active drugs
Hoffbrand, A. V. (1998) · Journal of Laboratory and Clinical Medicine · doi:10.1016/s0022-2143(98)90175-5 · Cited by 10
Research works printed but not linked: 1
- Olivieri, 1996, Long-term follow up of body iron in patients with thalassemia major during therapy with the orally active iron chelator deferiprone (LI), Blood, 88, 310a
Cited by
Kell, D. B. (2009) · BMC Medical Genomics · doi:10.1186/1755-8794-2-2 · Cited by 554
Cancer cell iron metabolism and the development of potent iron chelators as anti-tumour agents
Richardson, D. R., Kalinowski, D. S., Lau, S., Jansson, P. J., & Lovejoy, D. B. (2009) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2008.04.003 · Cited by 258
Self-citationIron chelators as therapeutic agents for the treatment of cancer
Richardson, D. R. (2002) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(01)00218-9 · Cited by 227
Self-citationWalcourt, A., Loyevsky, M., Lovejoy, D. B., Gordeuk, V. R., & Richardson, D. R. (2004) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(03)00248-6 · Cited by 211
Self-citationLight-triggered release of photocaged therapeutics - Where are we now?
Silva, J. M., Silva, E., & Reis, R. L. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.02.006 · Cited by 171
Metadata
- Authors
- Richardson, D. R., & Ponka, P.
- Venue
- Journal of Laboratory and Clinical Medicine
- Publisher
- Elsevier BV
- Published
- 1998-10
- Volume
- 132
- Issue
- 4
- Pages
- 351-352
- ISSN
- 0022-2143 (ISSN-L)
- OpenAlex
- W2086398450
- Cited by
- 25
- References
- 6
- Citations by year
- 2023: 1 · 2019: 1 · 2018: 3 · 2015: 2 · 2014: 2 · 2013: 2
- FWCI
- 0.21
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Journal of Laboratory and Clinical Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
- Keywords
- iron chelators, oral iron chelation, pyridoxal isonicotinoyl hydrazone, iron chelation therapy
- MeSH terms
- Deferiprone, Administration, Oral, Animals, Ferritins, Iron, Iron Chelating Agents, Isoniazid, Pyridones, Pyridoxal, Treatment Outcome, Iron Overload, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Orally effective iron chelators for the treatment of iron overload disease: The case for a further look at pyridoxal isonicotinoyl hydrazone and its analogs. https://app.cochat.ai/papers/10.1016/s0022-2143(98)90049-x
- The paper
- Richardson, D. R., & Ponka, P. (1998). Orally effective iron chelators for the treatment of iron overload disease: The case for a further look at pyridoxal isonicotinoyl hydrazone and its analogs. Journal of Laboratory and Clinical Medicine. https://doi.org/10.1016/s0022-2143(98)90049-x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.